Site Search
Search Results
Governor Newsom Signs Game-Changing Legislation Aimed at Improving Health Outcomes, Quality of Life for Californians
... testing when supported by medical and scientific evidence. The bill, sponsored by the American Cancer Society Cancer Action Network (ACS CAN) and the University of California, received strong, bipartisan support throughout the legislative process. “We thank the Legislature and Governor Newsom for taking this crucial step to turn the promise of precision medicine into a reality for more Californians. A longstanding leader in health equity and medical innovation, California joins twelve ...
Legislation Aimed at Improving Health Outcomes, Quality of Life for Californians Heads to the Governor’s Desk
... testing when supported by medical and scientific evidence. Senate Bill 496, sponsored by the American Cancer Society Cancer Action Network (ACS CAN) and the University of California, has received strong, bipartisan support throughout the legislative process. It now heads to the governor’s desk. “Biomarker ... can help health care providers render the right treatment at the right time and is increasingly important for cancer care and the treatment of diseases like arthritis and other autoimmune and rare diseases. With research happening in other areas, biomarkers may be available in the ...
California Assembly Committee Passes Legislation Requiring More Insurance Plans Cover Biomarker Testing Needed for Many Innovative Cancer Treatments
... Senate Bill 912 will enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for some cancer patients. But to determine if a patient will benefit from certain targeted therapies, doctors ... Ogden-Smith, California Legislative Director for the American Cancer Society Cancer Action Network (ACS CAN). “It’s imperative we dismantle cost barriers in order to address and help reduce health disparities.” Communities that have been under-resourced, including communities of ...
State Senate Committee Votes to Increase Access to Innovative Testing and Lifesaving Treatments
... evening to advance a bill that would increase access to biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients. Senate Bill 912 would ensure comprehensive biomarker testing is covered by more ... medical centers are less likely to receive recommended biomarker testing. “We urge the legislature to pass this bill to help dismantle cost barriers and bring the promise of precision medicine to more cancer patients, regardless of their income, race or zip code,” said Autumn J. ...
Senate Introduces Legislation to Increase Californians’ Access to Lifesaving Testing and Innovative Treatments
... Calif. — Today, State Senator Monique Limón (D-Santa Barbara) introduced Senate Bill 912 to increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. The American Cancer Society Cancer Action Network (ACS CAN) and the University of California (UC) have teamed up to sponsor this important next step in ensuring cancer patients have access to precision medicine. The UC system ... coverage of biomarker testing more broadly, I have introduced SB 912. The bill will reduce barriers patients face when accessing timely care and cost of treatment. SB 912 will improve access to care, precision medicine, and will reduce overall healthcare costs by avoiding unnecessary ...
Legislation Introduced to Increase Californians’ Access to Biomarker Testing, the Key to Precision Medicine
... enable more Californians to benefit from biomarker testing, a critical step for accessing precision medicine, including targeted therapies, that can lead to improved survivorship and better quality of life for cancer patients. “Biomarker testing can help healthcare providers render the best treatment options for patients, which is increasingly important for cancer care and the treatment of diseases like arthritis, other immune conditions and rare diseases,” said Sen. Limón. “This bill removes barriers to precision medicine and ...
More Californians with Cancer, Other Chronic Diseases, Get Access to Game-Changing Testing
Sacramento , Calif. – Gov. Gavin Newsom signed the state budget on June 29, allowing for Medi-Cal implementation of Senate Bill 496. Starting July 1st, Medi-Cal and other state-regulated health insurance plans will cover comprehensive biomarker testing ... Testing for specific biomarkers – such as gene mutations – found in blood, tissues or other biospecimens provides crucial information that can help determine the most effective treatment for a particular patient, including precision medicine and targeted therapies. “Nearly 60% of all cancer drugs approved in the last five years require or recommend biomarker testing before use. Improving coverage for biomarker testing ...